Type
1.
Villamizar-Monsalve MA, López-Abán J, Vicente B, Peláez R, Muro A. Current drug strategies for the treatment and control of schistosomiasis. Expert opinion on pharmacotherapy. 2024;:1-12.
Type
1.
Lubanga AF, Bwanali AN, Munthali LE, Mphepo M, Chumbi GD, Kangoma M, et al. Exploring the Role of Community Involvement in Reducing the Burden of Schistosomiasis and Other Neglected Tropical Diseases in Malawi: Where are We in the Fight Against Neglected Tropical Diseases?. Research and reports in tropical medicine [Internet]. 2024;15:51-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10909323/pdf/rrtm-15-51.pdf
Type
1.
Menezes CA, Montresor LC, Jangola STG, de Mattos AC, Domingues ALC, Júnior AM, et al. FioSchisto’s expert perspective on implementing WHO guidelines for schistosomiasis control and transmission elimination in Brazil. Frontiers in immunology [Internet]. 2023;14:1268998. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10739458/pdf/fimmu-14-1268998.pdf
Type
1.
Makaula P, Kayuni SA, Mamba KC, Bongololo G, Funsanani M, Juziwelo LT, et al. Mass drug administration campaigns: comparing two approaches for schistosomiasis and soil-transmitted helminths prevention and control in selected Southern Malawi districts. BMC health services research [Internet]. 2024;24(1):1-15. Available from: https://bmchealthservres.biomedcentral.com/counter/pdf/10.1186/s12913-023-10489-5.pdf
Type
1.
Singer BJ, Coulibaly JT, Park HJ, Andrews JR, Bogoch II, Lo NC. Development of prediction models to identify hotspots of schistosomiasis in endemic regions to guide mass drug administration. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2024;121(2). Available from: https://www.pnas.org/doi/10.1073/pnas.2315463120
Type
1.
Meier L, Antillon M, Burri C, Chitnis N, Endriss Y, Keiser J, et al. Repurposing Know-how for Drug Development: Case Studies from the Swiss Tropical and Public Health Institute. Chimia [Internet]. 2023;77(9):582-9. Available from: https://www.chimia.ch/chimia/article/view/2023_582/6292
Type
1.
Kabatende J, Ntirenganya L, Mugisha M, Barry A, Ruberanziza E, Bienvenu E, et al. Efficacy of Single-Dose Praziquantel for the Treatment of Infections among School Children in Rwanda. Pathogens (Basel, Switzerland) [Internet]. 2023;12(9):1-10. Available from: https://www.mdpi.com/2076-0817/12/9/1170/pdf?version=1694943649
Type
1.
Gabaake KP, Lucero-Prisno DE, Thakadu OT, Phaladze NA. A mixed method analysis of the Botswana schistosomiasis control policy and plans using the policy triangle framework. Global health research and policy [Internet]. 2023;8(1):1-13. Available from: https://ghrp.biomedcentral.com/counter/pdf/10.1186/s41256-023-00321-2.pdf?pdf=button%20sticky
Type
1.
Rasoamanamihaja CF, Rakotoarivelo RA, Edosoa G, Rasamoelina T, Montresor A, Marchese V, et al. Schistosomiasis elimination in Madagascar: challenges and opportunities for implementing the new WHO guidelines. BMJ global health [Internet]. 2023;8(8):1-8. Available from: https://gh.bmj.com/content/bmjgh/8/8/e012598.full.pdf
Type
1.
de Moraes J. Recent Advances in Drug Discovery for Parasitic Diseases. Current topics in medicinal chemistry. 2023;23(9):711-2.